Comparada com a terapia medicamentosa, como a cirurgia metabólica age na redução do Diabetes tipo 2?
DOI:
https://doi.org/10.34117/bjdv9n4-129Keywords:
qualidade de vida, gastrectomia, Diabetes Mellitus tipo 2, derivação gástrica, cirurgia bariátrica, tratamento farmacológicoAbstract
A diabetes mellitus tipo 2 (DM2) é uma doença crônica caracterizada por hiperglicemia e defeitos na ação e secreção de insulina. Este estudo tem o intuito de comparar a qualidade de vida de pacientes que optaram pelas cirurgias metabólicas ao invés das terapias medicamentosas tradicionais. Trata-se de uma Revisão Integrativa da Literatura, utilizando os seguintes bancos de dados: PubMed e Biblioteca Virtual em Saúde (BVS). Foram usados os seguintes descritores: ‘’Quality of Life’’, ‘’Gastrectomy’’, ‘’Diabetes Mellitus, Type 2’’, ‘’Gastric by-pass’’, ‘’Bariatric Surgery’’ e ‘’Drug therapy’’. O estudo permitiu comprovar a maior eficácia das técnicas cirúrgicas no controle da DM2. Comprovou-se alta remissão da DM2 nas cirurgias em comparação à terapia medicamentosa isolada.
References
BROSNAN, C. et al. Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present. Obes Surg, p. 1-11, ago. 2020.
FERRAZ, Á. A. B. et al. Roux-em-Y gastric by-pass for nonobese patients with uncontrolled type 2 diabetes: a long-term evaluation. Surgery for Obesity and Related Diases, v.15, p. 682-687, mai. 2019.
FENG, W. et al. Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes. Diabetes Metab Res Ver, v.35, p. 1-9, jul. 2019.
KHENISER, K. G.; KASHYAP, S. R. Diabetes management before, during, and after bariatric and metabolic surgery. Journal of Diabetes and its Complications, v. 32, n. 9, p. 870-875, 2018.
LAUBNER, K. et al. Comparative Characteristics of Patients with Type 2 Diabetes Mellitus Treated by Bariatric Surgery Versus Medical Treatment: a Multicentre Analysis of 277,862 Patients from the German/Austrian DPV Database. Obes Surg, v. 28, p. 3366-3373, jun. 2018
MULLA, C. M; BALOCH, H. M; HAFIDA, S. Management of Diabetes in Patients Undergoing Bariatric Surgery. Curr Diab Rep, v. 19, p. 1-11, nov. 2019.
IDF – INTERNATION DIABETES FEDERATION. IDF Diabetes Atlas, S. 9, p. 10-161, jan. 2019.
ROLIM, F. F. A. et al. Long-term repercussions of Roux-en-Y gastric bypass in a low-income population with diabetes mellitus: assessment ten years after surgery. Revista do Colegio Brasileiro de Cirurgiões, v. 45, n. 4, p. e1916, jun. 2018.
RAJAN, R.M.S. et al. Early outcome of bariatric surgery for the treatment of type 2 diabetes mellitus in super-obese Malaysian population. Journal of Minimal Access Surgery, v. 16, n. 1, p. 47, 2020.
SHARPLES, A.J.Q. et al. Effect of Roux-en-Y gastric bypass on pharmacologic dependence in obese patients with type 2 diabetes. Can J Surg. V. 62, p. 259-264, jun. 2019.
SIMONSON, D.C. et al. Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study. Diabetes Care, v. 41, p.670-679, abr. 2018.
SHA, Y. et al. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for type 2 diabetes mellitus in nonseverely obese patients: A systematic review and meta-analysis of randomized controlled trials. Obesity Surgery, p. 1-11, jan. 2020.
SEKI, Y. et al. Metabolic surgery for inadequately controlled type 2 diabetes in nonseverely obese Japanese: a prospective, single-center study. Surg Obes Relat Dis, v. 14, p.978-985, jul. 2018.
SEKI, Y. et al. Five-Year Outcomes of Laparoscopic Sleeve Gastrectomy in Japanese Patients with Class I Obesity. Obesity Surgery, v. 30, n. 11, p. 4366-4374, nov. 2020.
TAN, S.Y.T. et al. The Impact of Bariatric Surgery Compared to Medical Therapy on Health-Related Quality of Life in Subjects with Obesity and Type 2 Diabetes Mellitus. Obesity Surgery, p. 1-9, 2020.
WHO – WORLD HEALTH ORGANIZATION. Classification of diabetes mellitus, p.8-35, jan. 2019.
WHO – WORLD HEALTH ORGANIZATION. Diagnosis and Management of type 2 Diabetes. HEARTS-D, p. 8-35, mar. 2020.
ZUO, D. et al. Effects of bariatric surgery in Chinese with obesity and type 2 diabetes mellitus: A 3-year follow-up. Medicine, v. 99, n. 34, 2020.
